Literature DB >> 7249667

Computed tomography of fluid collections within the abdomen.

L Kreel, G M Bydder.   

Abstract

Computed tomography is ideally suited for detecting mass lesions and for distinguishing "solid" from "cystic" masses. In the majority of cases, the recognition of fluid collections is unequivocal and lead to direct management decisions. Subphrenic, intrahepatic, and subhepatic abscesses can be recognized, aspirated, and drained. Using CT control, pancreatic pseudocysts can be managed similarly. Renal cysts can be accurately diagnosed with CT, especially with contrast enhancement, and then even the occasional case in which hydronephrosis may be a problem can be distinguished. Very occasionally, solid tumors containing mucinous material or lipoid can appear as cystic lesions, especially in the suprarenal, ovary, liver, or lymph nodes, and, conversely, abscesses may have higher tissue attenuation values, suggesting a solid lesion. It is most important to ensure that bowel is adequately labeled with contrast so that is is not misdiagnosed as a mass lesion.

Entities:  

Mesh:

Year:  1980        PMID: 7249667     DOI: 10.1016/s0149-936x(80)80004-x

Source DB:  PubMed          Journal:  J Comput Tomogr        ISSN: 0149-936X


  3 in total

Review 1.  Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei.

Authors:  Veena Ramaswamy
Journal:  Indian J Surg Oncol       Date:  2016-03-19

2.  Bicytopenia as a paraneoplastic syndrome for pseudomyxoma peritonei. Hematologic manifestations of a subtle disease.

Authors:  Ciprian Tomuleasa; Bobe Petrushev; Madalina Vedean; Alexandru Irimie; Florin Zaharie; Ana-Maria Rosu; Delia Dima; Andrei Cucuianu
Journal:  Int J Gen Med       Date:  2015-03-02

Review 3.  Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects.

Authors:  Afshin Amini; Samar Masoumi-Moghaddam; Anahid Ehteda; David Lawson Morris
Journal:  Orphanet J Rare Dis       Date:  2014-05-05       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.